Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech

By Flavio RumpScience Life Sciences

Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech episodes

February 04, 2018 05 How Citizen Science Can Transform Drug Discovery with Ernst Hafen
In this episode, Prof. Ernst Hafen from ETH Zurich tells us how citizens can play a very important role in biomedical research and drug discovery. Recruiting the right patients for a study is a big challenge for biotech and pharma companies. He presents us his radical initiative midata.coop, which allows patients to store their health data in a secure way and allows them to participate in clinical studies. Part 1 of a very interesting interview.
31 min
January 26, 2018 04 Open Research in the Wild: How to get the most out of it with Dr. Rachel Harding
In this episode, we learn how Huntington's disease researcher Rachel Harding uses an open lab notebook to share her findings with the scientific community and writes a blog for a wider audience. Most science is not conducted like that and findings take a long while to be disseminated. What are the main benefits of doing open research? Why haven't more researchers adopted this yet? What areas of biomedical science are most suitable for open research?
38 min
January 26, 2018 04 Open Research with Dr. Rachel Harding
Open Research: How to build a collaborative research network through open lab notebook with Dr. Rachel Harding
38 min
January 19, 201803 ML for Drug Discovery & What is broken in cancer research with Sarah Constantin
Sarah Constantin is a mathematician & data scientist with a PhD from Yale.
We discover how
computer vision and machine learning can be used to do drug discovery
what the biggest challenges in today's cancer research
with potential solutions
29 min
January 12, 2018 02 Why 85% of biomedical research is wasted with Paul Glasziou
Prof Paul Glasziou is a practitioner and widely published clinical research expert. He explains how we waste billions of dollars on biomedical research.
Over 50% of all health research does not get published at all. From the published research, 50% is not usable in practice because things are missing. And from the 25% which is left, half contains design flaws. Hence, over 87.5% (which they rounded down to 85%) of health research is avoidably wasted according to Glasziou. We explore how this waste happens and what can be done about it.
37 min
January 06, 2018 01 Marcio von Muhlen - Github for Science
In this podcast, we get to know Marcio van Muehlen, a biological engineer from MIT turned entrepreneur & product manager in Silicon Valley. He was working on cancer diagnostics through blood sampling and wanted to have better access to the work from other scientists in the field. There he recognized early on that we need a github for science and published a widely referenced article on it in 2011. We talk about why we need a github for science, what has happened since he wrote the article and what is still preventing us from having more open collaboration.
48 min

About Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech

From the publisher's feed

In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of biotech by speaking with some of the sharpest, most innovative minds in biotechnology…